Active Penny Stocks in the News
PennyTrader.com presents a range of the hottest penny stocks on the OTC and OTCBB market today. In addition to daily hot stock alerts, PennyTrader.com‘s new penny stock alert service is fast becoming the premier stock alert list to be on.
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
Visteon Corporation (OTC: VSTNQ) was up 24.16% in morning trading to $1.85 with 4M shares traded. Visteon Corporation supplies automotive systems, modules, and components to automotive original equipment manufacturers, as well as to other suppliers and assemblers worldwide. Visteon Corporation (OTC: VSTNQ. ob - News) today announced its first-quarter 2010 results, reporting net income of $233 million, or $1.79 per share, on product sales of $1.85 billion. For the first quarter of 2009, Visteon reported a net income of $2 million, or 2 cents per share, on product sales of $1.3 billion. Adjusted EBITDA, as defined below, for the first quarter of 2010 was $161 million, compared with $22 million in the first quarter of 2009.
For detailed quote and full article http://www.pennytrader.com/quotes/VSTNQ.php
Clarient, Inc. (Nasdaq: CLRT) reached up 12.04% in morning trading to $3.07 with 490K shares traded. Clarient, Inc. (Nasdaq: CLRT - News), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the company is scheduled to make investor presentations at three investor conferences in the month of May.
For detailed quote and full article http://www.pennytrader.com/quotes/CLRT.php
Repros Therapeutics Inc. (Nasdaq: RPRX) was up 19.54% in morning trading to $1.04 with 8M shares traded. Repros Therapeutics, Inc., a development stage biopharmaceutical company, focuses on the development of oral small molecule drugs for the treatment of male and female reproductive disorders. Repros Therapeutics Inc. (NasdaqCM: RPRX) today announced that a teleconference was held with the FDA to review the clinical hold status of Proellex®.
For detailed quote and full article http://www.pennytrader.com/quotes/RPRX.php
Subscribe to our FREE penny stock email alert service by visiting http://www.pennytrader.com/sign-up/
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks
in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com has not been compensated for any stocks covered in this midday report
For complete disclosure information go to http://www.pennytrader.com/disclosure/
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to http://www.pennytrader.com/disclaimer/
